aegeline
← Previous: adrenosterone | 🏠 All Substances | 📊 Complete Table | Next: AH-7921 →
OPSS Properties
| Classifications | 6000 |
| Reason | FDA warning letter: New dietary ingredient lacking evidence for safe use; associated adverse events reported |
| Also Known As |
|
| Prohibited Because | FDA Warning Letter |
| Added to Database | December 30, 2025 |
| Source Last Updated | February 6, 2025 |
| GUID | 0c4a35d7-a541-4fc2-8c5a-4642176f3b69 |
References
- FDA warning letter: New dietary ingredient lacking evidence for safe use; associated adverse events reported
- NIH NCATS Inxight Drugs entry: Aegeline
External Resources
- FDA UNII Search
- GSRS Full Record
- NCATS Inxight Drugs
- CAS Common Chemistry
- PubChem
- EPA CompTox Dashboard
UNII: 60T59LN3SG · CAS: 456-12-2
PubChem Properties
Chemical Structure
Interactive 3D Structure
| Molecular Formula | C18H19NO3 |
| Molecular Weight | 297.3 g/mol |
| IUPAC Name | (E)-N-[2-hydroxy-2-(4-methoxyphenyl)ethyl]-3-phenylprop-2-enamide |
| InChIKey | QRFDENJATPJOKG-KPKJPENVSA-N |
📊 Complete Table | 🏠 All Substances
Substance 153 of 880